2.5% TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES IN 10% DEXTROSE SOLUTION

Country: Canada

Language: English

Source: Health Canada

Active ingredient:

DEXTROSE; L-LEUCINE; L-PHENYLALANINE; L-LYSINE (L-LYSINE HYDROCHLORIDE); METHIONINE; L-ISOLEUCINE; L-VALINE; HISTIDINE; L-THREONINE; TRYPTOPHAN; L-ALANINE; L-ARGININE; L-PROLINE; SERINE; GLYCINE; L-TYROSINE; SODIUM ACETATE; POTASSIUM PHOSPHATE DIBASIC; SODIUM CHLORIDE; MAGNESIUM CHLORIDE

Available from:

BAXTER CORPORATION CLINTEC NUTRITION DIVISION

ATC code:

B05BA10

INN (International Name):

COMBINATIONS

Dosage:

10G; 182.5MG; 140MG; 145MG; 100MG; 150MG; 145MG; 120MG; 105MG; 45MG; 520MG; 290MG; 170MG; 125MG; 260MG; 10MG; 170MG; 130.5MG; 29.3MG; 25.5MG

Pharmaceutical form:

SOLUTION

Composition:

DEXTROSE 10G; L-LEUCINE 182.5MG; L-PHENYLALANINE 140MG; L-LYSINE (L-LYSINE HYDROCHLORIDE) 145MG; METHIONINE 100MG; L-ISOLEUCINE 150MG; L-VALINE 145MG; HISTIDINE 120MG; L-THREONINE 105MG; TRYPTOPHAN 45MG; L-ALANINE 520MG; L-ARGININE 290MG; L-PROLINE 170MG; SERINE 125MG; GLYCINE 260MG; L-TYROSINE 10MG; SODIUM ACETATE 170MG; POTASSIUM PHOSPHATE DIBASIC 130.5MG; SODIUM CHLORIDE 29.3MG; MAGNESIUM CHLORIDE 25.5MG

Administration route:

INTRAVENOUS

Units in package:

2000 ML

Prescription type:

Ethical

Therapeutic area:

CALORIC AGENTS

Product summary:

Active ingredient group (AIG) number: 2050851008; AHFS:

Authorization status:

CANCELLED POST MARKET

Authorization date:

2015-08-05